Component
Human organic cation transporter 1 / OCT1 / SLC22A1
Human organic cation transporter 1 / OCT1 / SLC22A1. Species, exposure and limitations are retained in each linked claim.
14 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Human OCT1 expression increased concentration-dependent agmatine transport in HEK293 cells, with Km 18.73 ± 4.86 mM.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Human transporter expressed in HEK293 cells; radiolabeled agmatine.
- limitations
- An in vitro Km is not a target blood concentration or oral bioavailability estimate.
- nutrient_topic
- Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
- plain_language
- A transporter can admit the molecule, but its affinity matters.
- primary_references
- OCT2 and MATE1 provide bidirectional agmatine transport. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21128598/ · DOI 10.1021/mp100180a
- transport_effect
- raises Expression increased concentration-dependent agmatine transport into HEK293 cells.
- transport_pool
- the expressing cell Expression increased concentration-dependent agmatine transport into HEK293 cells.
Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 20–26
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human transporter expressed in HEK293 cells; radiolabeled agmatine. · source_derived_draft · unverified_draft
## agmatine-sulfate-oct1 A transporter can admit the molecule, but its affinity matters. Human OCT1 expression increased concentration-dependent agmatine transport in HEK293 cells, with Km 18.73 ± 4.86 mM. Model: Human transporter expressed in HEK293 cells; radiolabeled agmatine. Limitations: An in vitro Km is not a target blood concentration or oral bioavailability estimate. Evidence access: Primary abstract OCT2 and MATE1 provide bidirectional agmatine transport. · 2011 · https://pubmed.ncbi.nlm.nih.gov/21128598/ · DOI 10.1021/mp100180a
Complete structured claim and evidenceHuman OCT1 transported thiamine with approximately 9.5-fold lower affinity than mouse Oct1.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/berberine-research/33037045.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "61d53435dfc952ba419da91767e79c07d75e2a432d9d4a2afd0d8d2560d570fd", "start_char": 0, "end_char": 2298, "text_sha256": "61d53435dfc952ba419da91767e79c07d75e2a432d9d4a2afd0d8d2560d570fd"}
- experimental_model
- Human versus mouse transporter kinetics in transfected HEK293 cells
- exposure
- Thiamine and metformin transport; transporter chimeras
- limitations
- Human OCT1 affinity for thiamine was substantially lower than mouse Oct1. This is a shared-transporter connection, not proof berberine causes B1 deficiency.
- nutrient_topic
- Berberine research collection; topical membership is not evidence of a direct dietary effect. · Berberine
- organism
- Human OCT1 and mouse Oct1
- plain_language
- Vitamin B1 shares this transporter, but the mouse and human versions behave differently.
- primary_references
- [berberine-p33037045] Differences in Metformin and Thiamine Uptake between Human and Mouse Organic Cation Transporter 1: Structural Determinants and Potential Consequences for Intrahepatic Concentrations. (2020). https://pubmed.ncbi.nlm.nih.gov/33037045/ DOI: 10.1124/dmd.120.000170
- tissue_or_cell_type
- Cellular thiamine uptake
- transport_effect
- raises A species-affinity comparison, but the measurement is thiamine carried into the expressing cell, which stands for the hepatocyte.
- transport_pool
- the hepatocyte interior A species-affinity comparison, but the measurement is thiamine carried into the expressing cell, which stands for the hepatocyte.
Berberine: metabolism, nutrient connections and drug interactions (2026-09-17) · lines 298–309
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human versus mouse transporter kinetics in transfected HEK293 cells · source_derived_draft · unverified_draft
### berberine-human-thiamine-transport Human OCT1 transported thiamine with approximately 9.5-fold lower affinity than mouse Oct1. Condition category: normal nutrient_topic: Berberine research collection; topical membership is not evidence of a direct dietary effect. plain_language: Vitamin B1 shares this transporter, but the mouse and human versions behave differently. organism: Human OCT1 and mouse Oct1 tissue_or_cell_type: Cellular thiamine uptake experimental_model: Human versus mouse transporter kinetics in transfected HEK293 cells limitations: Human OCT1 affinity for thiamine was substantially lower than mouse Oct1. This is a shared-transporter connection, not proof berberine causes B1 deficiency. exposure: Thiamine and metformin transport; transporter chimeras evidence_span: {"source_cache": "artifacts/berberine-research/33037045.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "61d53435dfc952ba419da91767e79c07d75e2a432d9d4a2afd0d8d2560d570fd", "start_char": 0, "end_char": 2298, "text_sha256": "61d53435dfc952ba419da91767e79c07d75e2a432d9d4a2afd0d8d2560d570fd"} [berberine-p33037045] Differences in Metformin and Thiamine Uptake between Human and Mouse Organic Cation Transporter 1: Structural Determinants and Potential Consequences for Intrahepatic Concentrations. (2020). https://pubmed.ncbi.nlm.nih.gov/33037045/ DOI: 10.1124/dmd.120.000170
Complete structured claim and evidencePoor OCT1 transporters did not show a difference in human berberine pharmacokinetics despite reduced uptake by variant OCT1 in vitro.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/berberine-research/39488825.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "ba324da62a36391435595fd7c4de2a848aae714abd4df063433362e4fdddce33", "start_char": 0, "end_char": 1787, "text_sha256": "ba324da62a36391435595fd7c4de2a848aae714abd4df063433362e4fdddce33"}
- experimental_model
- Transporter kinetics, mouse perfusion and human genotype-stratified pharmacokinetics
- exposure
- Oral berberine; OCT1 and CYP2D6 functional variants; sex-stratified analysis
- limitations
- Human OCT1 null finding differs from cellular and mouse findings. Sex-specific CYP2D6 result is not a universal rule for all formulations or a dosing algorithm.
- nutrient_topic
- Berberine research collection; topical membership is not evidence of a direct dietary effect. · Berberine
- organism
- Human participants and human OCT1; Oct1/2-deficient mice in separate arms
- plain_language
- A cell-transport difference did not translate into a detected blood-level difference.
- primary_references
- [berberine-p39488825] Sex-Dependent Effects of CYP2D6 on the Pharmacokinetics of Berberine in Humans. (2025). https://pubmed.ncbi.nlm.nih.gov/39488825/ DOI: 10.1002/cpt.3454
- tissue_or_cell_type
- Liver transport and systemic exposure
Berberine: metabolism, nutrient connections and drug interactions (2026-09-17) · lines 259–270
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Transporter kinetics, mouse perfusion and human genotype-stratified pharmacokinetics · source_derived_draft · unverified_draft
### berberine-oct1-genotype-null Poor OCT1 transporters did not show a difference in human berberine pharmacokinetics despite reduced uptake by variant OCT1 in vitro. Condition category: normal nutrient_topic: Berberine research collection; topical membership is not evidence of a direct dietary effect. plain_language: A cell-transport difference did not translate into a detected blood-level difference. organism: Human participants and human OCT1; Oct1/2-deficient mice in separate arms tissue_or_cell_type: Liver transport and systemic exposure experimental_model: Transporter kinetics, mouse perfusion and human genotype-stratified pharmacokinetics limitations: Human OCT1 null finding differs from cellular and mouse findings. Sex-specific CYP2D6 result is not a universal rule for all formulations or a dosing algorithm. exposure: Oral berberine; OCT1 and CYP2D6 functional variants; sex-stratified analysis evidence_span: {"source_cache": "artifacts/berberine-research/39488825.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "ba324da62a36391435595fd7c4de2a848aae714abd4df063433362e4fdddce33", "start_char": 0, "end_char": 1787, "text_sha256": "ba324da62a36391435595fd7c4de2a848aae714abd4df063433362e4fdddce33"} [berberine-p39488825] Sex-Dependent Effects of CYP2D6 on the Pharmacokinetics of Berberine in Humans. (2025). https://pubmed.ncbi.nlm.nih.gov/39488825/ DOI: 10.1002/cpt.3454
Complete structured claim and evidenceHuman OCT1 transported berberine in transfected cells, with reported Km 14.8 micromolar.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/berberine-research/18157518.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "34651ed2e9ce3c38b6042e616b5c36d932fe6f1099c627d1b5403b338eae7b2b", "start_char": 0, "end_char": 1918, "text_sha256": "34651ed2e9ce3c38b6042e616b5c36d932fe6f1099c627d1b5403b338eae7b2b"}
- experimental_model
- Polarized transporter-transfected MDCKII cells
- exposure
- Berberine transport kinetics and transporter inhibition
- limitations
- Engineered system, not direct evidence for human oral bioavailability or a universal transport bottleneck.
- nutrient_topic
- Berberine research collection; topical membership is not evidence of a direct dietary effect. · Berberine
- organism
- Human OCT1, OCT2 and ABCB1 in engineered canine cells
- plain_language
- Berberine uses a separately identified organic-cation uptake transporter.
- primary_references
- [berberine-p18157518] Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1). (2008). https://pubmed.ncbi.nlm.nih.gov/18157518/ DOI: 10.1007/s00210-007-0219-x
- tissue_or_cell_type
- Basolateral uptake and apical export
- transport_effect
- raises Berberine uptake measured in transfected cells, which stand for the hepatocyte, with a reported Km of 14.8 micromolar.
- transport_pool
- the hepatocyte interior Berberine uptake measured in transfected cells, which stand for the hepatocyte, with a reported Km of 14.8 micromolar.
Berberine: metabolism, nutrient connections and drug interactions (2026-09-17) · lines 207–218
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Polarized transporter-transfected MDCKII cells · source_derived_draft · unverified_draft
### berberine-uptake-oct1 Human OCT1 transported berberine in transfected cells, with reported Km 14.8 micromolar. Condition category: normal nutrient_topic: Berberine research collection; topical membership is not evidence of a direct dietary effect. plain_language: Berberine uses a separately identified organic-cation uptake transporter. organism: Human OCT1, OCT2 and ABCB1 in engineered canine cells tissue_or_cell_type: Basolateral uptake and apical export experimental_model: Polarized transporter-transfected MDCKII cells limitations: Engineered system, not direct evidence for human oral bioavailability or a universal transport bottleneck. exposure: Berberine transport kinetics and transporter inhibition evidence_span: {"source_cache": "artifacts/berberine-research/18157518.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "34651ed2e9ce3c38b6042e616b5c36d932fe6f1099c627d1b5403b338eae7b2b", "start_char": 0, "end_char": 1918, "text_sha256": "34651ed2e9ce3c38b6042e616b5c36d932fe6f1099c627d1b5403b338eae7b2b"} [berberine-p18157518] Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1). (2008). https://pubmed.ncbi.nlm.nih.gov/18157518/ DOI: 10.1007/s00210-007-0219-x
Complete structured claim and evidenceThe affinity for metformin was 4.9-fold lower in human than in mouse OCT1, giving a 6.5-fold lower intrinsic clearance and an estimated liver-to-blood partition coefficient of 3.34 in human compared with 14.4 in mouse.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/metformin-research/33037045.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "861e39b20a78d5d85a01c5de0febda8bf1c400de4fa8ef1e6944707521604c67", "start_char": 0, "end_char": 2296, "text_sha256": "861e39b20a78d5d85a01c5de0febda8bf1c400de4fa8ef1e6944707521604c67"}
- experimental_model
- Stably transfected HEK293 cells comparing human and mouse OCT1, with human-mouse chimeras and homology modelling
- exposure
- Metformin and thiamine uptake kinetics; transmembrane-helix substitutions
- limitations
- A species comparison of transport affinity. It limits how far mouse OCT1 results can be read as human ones; it is not itself a human tissue measurement.
- nutrient_topic
- Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. · Metformin
- organism
- Human and mouse orthologues side by side
- plain_language
- The mouse liver concentrates this drug far more than the human liver does.
- primary_references
- [metformin-p33037045] Differences in Metformin and Thiamine Uptake between Human and Mouse Organic Cation Transporter 1: Structural Determinants and Potential Consequences for Intrahepatic Concentrations. (2020). https://pubmed.ncbi.nlm.nih.gov/33037045/ DOI: 10.1124/dmd.120.000170
- tissue_or_cell_type
- Hepatic uptake
Metformin: transport, molecular targets, gut mechanisms and nutrient interactions (2026-09-19) · lines 320–331
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Stably transfected HEK293 cells comparing human and mouse OCT1, with human-mouse chimeras and homology modelling · source_derived_draft · unverified_draft
### metformin-oct1-species-metformin The affinity for metformin was 4.9-fold lower in human than in mouse OCT1, giving a 6.5-fold lower intrinsic clearance and an estimated liver-to-blood partition coefficient of 3.34 in human compared with 14.4 in mouse. Condition category: normal nutrient_topic: Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. plain_language: The mouse liver concentrates this drug far more than the human liver does. organism: Human and mouse orthologues side by side tissue_or_cell_type: Hepatic uptake experimental_model: Stably transfected HEK293 cells comparing human and mouse OCT1, with human-mouse chimeras and homology modelling limitations: A species comparison of transport affinity. It limits how far mouse OCT1 results can be read as human ones; it is not itself a human tissue measurement. exposure: Metformin and thiamine uptake kinetics; transmembrane-helix substitutions evidence_span: {"source_cache": "artifacts/metformin-research/33037045.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "861e39b20a78d5d85a01c5de0febda8bf1c400de4fa8ef1e6944707521604c67", "start_char": 0, "end_char": 2296, "text_sha256": "861e39b20a78d5d85a01c5de0febda8bf1c400de4fa8ef1e6944707521604c67"} [metformin-p33037045] Differences in Metformin and Thiamine Uptake between Human and Mouse Organic Cation Transporter 1: Structural Determinants and Potential Consequences for Intrahepatic Concentrations. (2020). https://pubmed.ncbi.nlm.nih.gov/33037045/ DOI: 10.1124/dmd.120.000170
Complete structured claim and evidenceThe affinity for thiamine was 9.5-fold lower in human than in mouse OCT1.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/metformin-research/33037045.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "861e39b20a78d5d85a01c5de0febda8bf1c400de4fa8ef1e6944707521604c67", "start_char": 0, "end_char": 2296, "text_sha256": "861e39b20a78d5d85a01c5de0febda8bf1c400de4fa8ef1e6944707521604c67"}
- experimental_model
- Stably transfected HEK293 cells comparing human and mouse OCT1, with human-mouse chimeras and homology modelling
- exposure
- Metformin and thiamine uptake kinetics; transmembrane-helix substitutions
- limitations
- A species comparison of transport affinity. It limits how far mouse OCT1 results can be read as human ones; it is not itself a human tissue measurement.
- nutrient_topic
- Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. · Metformin
- organism
- Human and mouse orthologues side by side
- plain_language
- The same species gap applies to the vitamin the transporter carries.
- primary_references
- [metformin-p33037045] Differences in Metformin and Thiamine Uptake between Human and Mouse Organic Cation Transporter 1: Structural Determinants and Potential Consequences for Intrahepatic Concentrations. (2020). https://pubmed.ncbi.nlm.nih.gov/33037045/ DOI: 10.1124/dmd.120.000170
- tissue_or_cell_type
- Hepatic uptake
Metformin: transport, molecular targets, gut mechanisms and nutrient interactions (2026-09-19) · lines 333–344
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Stably transfected HEK293 cells comparing human and mouse OCT1, with human-mouse chimeras and homology modelling · source_derived_draft · unverified_draft
### metformin-oct1-species-thiamine The affinity for thiamine was 9.5-fold lower in human than in mouse OCT1. Condition category: normal nutrient_topic: Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. plain_language: The same species gap applies to the vitamin the transporter carries. organism: Human and mouse orthologues side by side tissue_or_cell_type: Hepatic uptake experimental_model: Stably transfected HEK293 cells comparing human and mouse OCT1, with human-mouse chimeras and homology modelling limitations: A species comparison of transport affinity. It limits how far mouse OCT1 results can be read as human ones; it is not itself a human tissue measurement. exposure: Metformin and thiamine uptake kinetics; transmembrane-helix substitutions evidence_span: {"source_cache": "artifacts/metformin-research/33037045.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "861e39b20a78d5d85a01c5de0febda8bf1c400de4fa8ef1e6944707521604c67", "start_char": 0, "end_char": 2296, "text_sha256": "861e39b20a78d5d85a01c5de0febda8bf1c400de4fa8ef1e6944707521604c67"} [metformin-p33037045] Differences in Metformin and Thiamine Uptake between Human and Mouse Organic Cation Transporter 1: Structural Determinants and Potential Consequences for Intrahepatic Concentrations. (2020). https://pubmed.ncbi.nlm.nih.gov/33037045/ DOI: 10.1124/dmd.120.000170
Complete structured claim and evidenceMetabolomic and isotopic uptake methods identified thiamine as a principal endogenous substrate of OCT1.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/metformin-research/24961373.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "77be4a228b3d067ca1e7ba44e8148f5fbda7956a23b42fb8281e9faf451a0e70", "start_char": 0, "end_char": 1270, "text_sha256": "77be4a228b3d067ca1e7ba44e8148f5fbda7956a23b42fb8281e9faf451a0e70"}
- experimental_model
- Oct1-knockout and human OCT1 transgenic mice, metabolomics and isotopic uptake
- exposure
- Metformin and phenformin against thiamine uptake; acute metformin in wild-type mice
- limitations
- Identifies thiamine as an endogenous OCT1 substrate and shows competitive inhibition by metformin. The steatosis phenotype is a mouse phenotype.
- nutrient_topic
- Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. · Metformin
- organism
- Mouse and human transporter
- plain_language
- The transporter that carries the drug into the liver normally carries vitamin B1.
- primary_references
- [metformin-p24961373] OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin. (2014). https://pubmed.ncbi.nlm.nih.gov/24961373/ DOI: 10.1073/pnas.1314939111
- tissue_or_cell_type
- Liver and intestine
- transport_effect
- raises Identified by isotopic uptake as a principal endogenous substrate.
- transport_pool
- the expressing cell Identified by isotopic uptake as a principal endogenous substrate.
Metformin: transport, molecular targets, gut mechanisms and nutrient interactions (2026-09-19) · lines 1230–1241
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Oct1-knockout and human OCT1 transgenic mice, metabolomics and isotopic uptake · source_derived_draft · unverified_draft
### metformin-oct1-thiamine-substrate Metabolomic and isotopic uptake methods identified thiamine as a principal endogenous substrate of OCT1. Condition category: normal nutrient_topic: Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. plain_language: The transporter that carries the drug into the liver normally carries vitamin B1. organism: Mouse and human transporter tissue_or_cell_type: Liver and intestine experimental_model: Oct1-knockout and human OCT1 transgenic mice, metabolomics and isotopic uptake limitations: Identifies thiamine as an endogenous OCT1 substrate and shows competitive inhibition by metformin. The steatosis phenotype is a mouse phenotype. exposure: Metformin and phenformin against thiamine uptake; acute metformin in wild-type mice evidence_span: {"source_cache": "artifacts/metformin-research/24961373.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "77be4a228b3d067ca1e7ba44e8148f5fbda7956a23b42fb8281e9faf451a0e70", "start_char": 0, "end_char": 1270, "text_sha256": "77be4a228b3d067ca1e7ba44e8148f5fbda7956a23b42fb8281e9faf451a0e70"} [metformin-p24961373] OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin. (2014). https://pubmed.ncbi.nlm.nih.gov/24961373/ DOI: 10.1073/pnas.1314939111
Complete structured claim and evidence
Where it participates (unsigned role)
OCT1/ABCB1 double-transfected cells transported berberine basolaterally to apically faster than single transfectants; zosuquidar inhibited apical efflux.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/berberine-research/18157518.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "34651ed2e9ce3c38b6042e616b5c36d932fe6f1099c627d1b5403b338eae7b2b", "start_char": 0, "end_char": 1918, "text_sha256": "34651ed2e9ce3c38b6042e616b5c36d932fe6f1099c627d1b5403b338eae7b2b"}
- experimental_model
- Polarized transporter-transfected MDCKII cells
- exposure
- Berberine transport kinetics and transporter inhibition
- limitations
- Engineered system, not direct evidence for human oral bioavailability or a universal transport bottleneck.
- nutrient_topic
- Berberine research collection; topical membership is not evidence of a direct dietary effect. · Berberine
- organism
- Human OCT1, OCT2 and ABCB1 in engineered canine cells
- plain_language
- An entry transporter and an exit pump can work in sequence.
- primary_references
- [berberine-p18157518] Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1). (2008). https://pubmed.ncbi.nlm.nih.gov/18157518/ DOI: 10.1007/s00210-007-0219-x
- tissue_or_cell_type
- Basolateral uptake and apical export
- transport_effect
- lowers Basolateral-to-apical flux exceeded absorptive flux and zosuquidar inhibited the apical efflux, so the step removes berberine from the cell.
- transport_pool
- the enterocyte interior Basolateral-to-apical flux exceeded absorptive flux and zosuquidar inhibited the apical efflux, so the step removes berberine from the cell.
Berberine: metabolism, nutrient connections and drug interactions (2026-09-17) · lines 233–244
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Polarized transporter-transfected MDCKII cells · source_derived_draft · unverified_draft
### berberine-abcb1-efflux OCT1/ABCB1 double-transfected cells transported berberine basolaterally to apically faster than single transfectants; zosuquidar inhibited apical efflux. Condition category: normal nutrient_topic: Berberine research collection; topical membership is not evidence of a direct dietary effect. plain_language: An entry transporter and an exit pump can work in sequence. organism: Human OCT1, OCT2 and ABCB1 in engineered canine cells tissue_or_cell_type: Basolateral uptake and apical export experimental_model: Polarized transporter-transfected MDCKII cells limitations: Engineered system, not direct evidence for human oral bioavailability or a universal transport bottleneck. exposure: Berberine transport kinetics and transporter inhibition evidence_span: {"source_cache": "artifacts/berberine-research/18157518.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "34651ed2e9ce3c38b6042e616b5c36d932fe6f1099c627d1b5403b338eae7b2b", "start_char": 0, "end_char": 1918, "text_sha256": "34651ed2e9ce3c38b6042e616b5c36d932fe6f1099c627d1b5403b338eae7b2b"} [berberine-p18157518] Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1). (2008). https://pubmed.ncbi.nlm.nih.gov/18157518/ DOI: 10.1007/s00210-007-0219-x
Complete structured claim and evidenceMetformin and the biguanide analogue phenformin competitively inhibited OCT1-mediated thiamine uptake.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/metformin-research/24961373.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "77be4a228b3d067ca1e7ba44e8148f5fbda7956a23b42fb8281e9faf451a0e70", "start_char": 0, "end_char": 1270, "text_sha256": "77be4a228b3d067ca1e7ba44e8148f5fbda7956a23b42fb8281e9faf451a0e70"}
- experimental_model
- Oct1-knockout and human OCT1 transgenic mice, metabolomics and isotopic uptake
- exposure
- Metformin and phenformin against thiamine uptake; acute metformin in wild-type mice
- limitations
- Identifies thiamine as an endogenous OCT1 substrate and shows competitive inhibition by metformin. The steatosis phenotype is a mouse phenotype.
- nutrient_topic
- Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. · Metformin
- organism
- Mouse and human transporter
- plain_language
- The drug and the vitamin compete for the same door.
- primary_references
- [metformin-p24961373] OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin. (2014). https://pubmed.ncbi.nlm.nih.gov/24961373/ DOI: 10.1073/pnas.1314939111
- tissue_or_cell_type
- Liver and intestine
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Metformin: transport, molecular targets, gut mechanisms and nutrient interactions (2026-09-19) · lines 1243–1254
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Oct1-knockout and human OCT1 transgenic mice, metabolomics and isotopic uptake · source_derived_draft · unverified_draft
### metformin-metformin-thiamine-competition Metformin and the biguanide analogue phenformin competitively inhibited OCT1-mediated thiamine uptake. Condition category: nutrient_deficiency nutrient_topic: Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. plain_language: The drug and the vitamin compete for the same door. organism: Mouse and human transporter tissue_or_cell_type: Liver and intestine experimental_model: Oct1-knockout and human OCT1 transgenic mice, metabolomics and isotopic uptake limitations: Identifies thiamine as an endogenous OCT1 substrate and shows competitive inhibition by metformin. The steatosis phenotype is a mouse phenotype. exposure: Metformin and phenformin against thiamine uptake; acute metformin in wild-type mice evidence_span: {"source_cache": "artifacts/metformin-research/24961373.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "77be4a228b3d067ca1e7ba44e8148f5fbda7956a23b42fb8281e9faf451a0e70", "start_char": 0, "end_char": 1270, "text_sha256": "77be4a228b3d067ca1e7ba44e8148f5fbda7956a23b42fb8281e9faf451a0e70"} [metformin-p24961373] OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin. (2014). https://pubmed.ncbi.nlm.nih.gov/24961373/ DOI: 10.1073/pnas.1314939111
Complete structured claim and evidenceCarriage of two reduced-function OCT1 alleles was associated with metformin intolerance (odds ratio 2.41), rising to 4.13 in people also taking OCT1-inhibiting drugs.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/metformin-research/25510240.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "f8eaf94237679ed7436f863e210d17b13a7219d064e46e7da915ed083c5b04c9", "start_char": 0, "end_char": 1355, "text_sha256": "f8eaf94237679ed7436f863e210d17b13a7219d064e46e7da915ed083c5b04c9"}
- experimental_model
- Case-control comparison of 251 metformin-intolerant and 1915 tolerant people in GoDARTS
- exposure
- Prescribed metformin, OCT1 genotype and co-prescribed OCT1 inhibitors
- limitations
- An association study. Intolerance is self-evidently multifactorial, and the proposed intestinal-concentration mechanism was not measured here.
- nutrient_topic
- Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. · Metformin
- organism
- Human
- plain_language
- The transporter that controls where the drug goes is also linked to who cannot tolerate it.
- primary_references
- [metformin-p25510240] Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study. (2015). https://pubmed.ncbi.nlm.nih.gov/25510240/ DOI: 10.2337/db14-1388
- tissue_or_cell_type
- Gastrointestinal tolerance
Metformin: transport, molecular targets, gut mechanisms and nutrient interactions (2026-09-19) · lines 359–370
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Case-control comparison of 251 metformin-intolerant and 1915 tolerant people in GoDARTS · source_derived_draft · unverified_draft
### metformin-oct1-intolerance Carriage of two reduced-function OCT1 alleles was associated with metformin intolerance (odds ratio 2.41), rising to 4.13 in people also taking OCT1-inhibiting drugs. Condition category: normal nutrient_topic: Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. plain_language: The transporter that controls where the drug goes is also linked to who cannot tolerate it. organism: Human tissue_or_cell_type: Gastrointestinal tolerance experimental_model: Case-control comparison of 251 metformin-intolerant and 1915 tolerant people in GoDARTS limitations: An association study. Intolerance is self-evidently multifactorial, and the proposed intestinal-concentration mechanism was not measured here. exposure: Prescribed metformin, OCT1 genotype and co-prescribed OCT1 inhibitors evidence_span: {"source_cache": "artifacts/metformin-research/25510240.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "f8eaf94237679ed7436f863e210d17b13a7219d064e46e7da915ed083c5b04c9", "start_char": 0, "end_char": 1355, "text_sha256": "f8eaf94237679ed7436f863e210d17b13a7219d064e46e7da915ed083c5b04c9"} [metformin-p25510240] Association of Organic Cation Transporter 1 With Intolerance to Metformin in Type 2 Diabetes: A GoDARTS Study. (2015). https://pubmed.ncbi.nlm.nih.gov/25510240/ DOI: 10.2337/db14-1388
Complete structured claim and evidenceSimultaneous substitution of transmembrane helices TMH2 and TMH3 reversed the affinity for metformin in human-mouse chimeric OCT1.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/metformin-research/33037045.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "861e39b20a78d5d85a01c5de0febda8bf1c400de4fa8ef1e6944707521604c67", "start_char": 0, "end_char": 2296, "text_sha256": "861e39b20a78d5d85a01c5de0febda8bf1c400de4fa8ef1e6944707521604c67"}
- experimental_model
- Stably transfected HEK293 cells comparing human and mouse OCT1, with human-mouse chimeras and homology modelling
- exposure
- Metformin and thiamine uptake kinetics; transmembrane-helix substitutions
- limitations
- A species comparison of transport affinity. It limits how far mouse OCT1 results can be read as human ones; it is not itself a human tissue measurement.
- nutrient_topic
- Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. · Metformin
- organism
- Human and mouse orthologues side by side
- plain_language
- Two helices carry the species difference in how tightly the drug binds.
- primary_references
- [metformin-p33037045] Differences in Metformin and Thiamine Uptake between Human and Mouse Organic Cation Transporter 1: Structural Determinants and Potential Consequences for Intrahepatic Concentrations. (2020). https://pubmed.ncbi.nlm.nih.gov/33037045/ DOI: 10.1124/dmd.120.000170
- tissue_or_cell_type
- Hepatic uptake
Metformin: transport, molecular targets, gut mechanisms and nutrient interactions (2026-09-19) · lines 346–357
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Stably transfected HEK293 cells comparing human and mouse OCT1, with human-mouse chimeras and homology modelling · source_derived_draft · unverified_draft
### metformin-oct1-tmh-determinant Simultaneous substitution of transmembrane helices TMH2 and TMH3 reversed the affinity for metformin in human-mouse chimeric OCT1. Condition category: normal nutrient_topic: Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. plain_language: Two helices carry the species difference in how tightly the drug binds. organism: Human and mouse orthologues side by side tissue_or_cell_type: Hepatic uptake experimental_model: Stably transfected HEK293 cells comparing human and mouse OCT1, with human-mouse chimeras and homology modelling limitations: A species comparison of transport affinity. It limits how far mouse OCT1 results can be read as human ones; it is not itself a human tissue measurement. exposure: Metformin and thiamine uptake kinetics; transmembrane-helix substitutions evidence_span: {"source_cache": "artifacts/metformin-research/33037045.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "861e39b20a78d5d85a01c5de0febda8bf1c400de4fa8ef1e6944707521604c67", "start_char": 0, "end_char": 2296, "text_sha256": "861e39b20a78d5d85a01c5de0febda8bf1c400de4fa8ef1e6944707521604c67"} [metformin-p33037045] Differences in Metformin and Thiamine Uptake between Human and Mouse Organic Cation Transporter 1: Structural Determinants and Potential Consequences for Intrahepatic Concentrations. (2020). https://pubmed.ncbi.nlm.nih.gov/33037045/ DOI: 10.1124/dmd.120.000170
Complete structured claim and evidenceIn clinical studies the effects of metformin in glucose tolerance tests were significantly smaller in people carrying reduced-function OCT1 polymorphisms.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/metformin-research/17476361.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e8d05affc6b49c7273e21804d2ad9092ca826c8d81431ee093c6215f18f0bce1", "start_char": 0, "end_char": 1361, "text_sha256": "e8d05affc6b49c7273e21804d2ad9092ca826c8d81431ee093c6215f18f0bce1"}
- experimental_model
- Oct1-knockout mouse hepatocytes and mice, human variant uptake assays, and human glucose-tolerance studies
- exposure
- Metformin in Oct1-deficient mice; seven non-synonymous human OCT1 variants; clinical glucose tolerance tests
- limitations
- Pharmacogenetic association with drug response, not proof that OCT1 genotype should guide prescribing.
- nutrient_topic
- Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. · Metformin
- organism
- Mouse and human, stated per record
- plain_language
- People who carry a weaker version of the transporter responded less to the drug.
- primary_references
- [metformin-p17476361] Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. (2007). https://pubmed.ncbi.nlm.nih.gov/17476361/ DOI: 10.1172/jci30558
- tissue_or_cell_type
- Hepatocytes and whole body
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Metformin: transport, molecular targets, gut mechanisms and nutrient interactions (2026-09-19) · lines 164–175
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Oct1-knockout mouse hepatocytes and mice, human variant uptake assays, and human glucose-tolerance studies · source_derived_draft · unverified_draft
### metformin-oct1-variants-response In clinical studies the effects of metformin in glucose tolerance tests were significantly smaller in people carrying reduced-function OCT1 polymorphisms. Condition category: machinery_impairment nutrient_topic: Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. plain_language: People who carry a weaker version of the transporter responded less to the drug. organism: Mouse and human, stated per record tissue_or_cell_type: Hepatocytes and whole body experimental_model: Oct1-knockout mouse hepatocytes and mice, human variant uptake assays, and human glucose-tolerance studies limitations: Pharmacogenetic association with drug response, not proof that OCT1 genotype should guide prescribing. exposure: Metformin in Oct1-deficient mice; seven non-synonymous human OCT1 variants; clinical glucose tolerance tests evidence_span: {"source_cache": "artifacts/metformin-research/17476361.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e8d05affc6b49c7273e21804d2ad9092ca826c8d81431ee093c6215f18f0bce1", "start_char": 0, "end_char": 1361, "text_sha256": "e8d05affc6b49c7273e21804d2ad9092ca826c8d81431ee093c6215f18f0bce1"} [metformin-p17476361] Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. (2007). https://pubmed.ncbi.nlm.nih.gov/17476361/ DOI: 10.1172/jci30558
Complete structured claim and evidenceSeven non-synonymous OCT1 polymorphisms showed reduced metformin uptake, including OCT1-420del, which has normal activity for model substrates.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/metformin-research/17476361.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e8d05affc6b49c7273e21804d2ad9092ca826c8d81431ee093c6215f18f0bce1", "start_char": 0, "end_char": 1361, "text_sha256": "e8d05affc6b49c7273e21804d2ad9092ca826c8d81431ee093c6215f18f0bce1"}
- experimental_model
- Oct1-knockout mouse hepatocytes and mice, human variant uptake assays, and human glucose-tolerance studies
- exposure
- Metformin in Oct1-deficient mice; seven non-synonymous human OCT1 variants; clinical glucose tolerance tests
- limitations
- Pharmacogenetic association with drug response, not proof that OCT1 genotype should guide prescribing.
- nutrient_topic
- Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. · Metformin
- organism
- Mouse and human, stated per record
- plain_language
- A transporter can look normal on a test substrate and still handle this drug poorly.
- primary_references
- [metformin-p17476361] Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. (2007). https://pubmed.ncbi.nlm.nih.gov/17476361/ DOI: 10.1172/jci30558
- tissue_or_cell_type
- Hepatocytes and whole body
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Metformin: transport, molecular targets, gut mechanisms and nutrient interactions (2026-09-19) · lines 125–136
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Oct1-knockout mouse hepatocytes and mice, human variant uptake assays, and human glucose-tolerance studies · source_derived_draft · unverified_draft
### metformin-oct1-variants-uptake Seven non-synonymous OCT1 polymorphisms showed reduced metformin uptake, including OCT1-420del, which has normal activity for model substrates. Condition category: machinery_impairment nutrient_topic: Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. plain_language: A transporter can look normal on a test substrate and still handle this drug poorly. organism: Mouse and human, stated per record tissue_or_cell_type: Hepatocytes and whole body experimental_model: Oct1-knockout mouse hepatocytes and mice, human variant uptake assays, and human glucose-tolerance studies limitations: Pharmacogenetic association with drug response, not proof that OCT1 genotype should guide prescribing. exposure: Metformin in Oct1-deficient mice; seven non-synonymous human OCT1 variants; clinical glucose tolerance tests evidence_span: {"source_cache": "artifacts/metformin-research/17476361.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "e8d05affc6b49c7273e21804d2ad9092ca826c8d81431ee093c6215f18f0bce1", "start_char": 0, "end_char": 1361, "text_sha256": "e8d05affc6b49c7273e21804d2ad9092ca826c8d81431ee093c6215f18f0bce1"} [metformin-p17476361] Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. (2007). https://pubmed.ncbi.nlm.nih.gov/17476361/ DOI: 10.1172/jci30558
Complete structured claim and evidenceHuman and rat OCT2 had roughly 10-fold and 100-fold greater capacity to transport metformin than OCT1 in the transfected-cell comparison.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/metformin-research/16272756.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9da4317752d37da62129139affd33016e879d367c4cf58cfefb9200c663fe4ed", "start_char": 0, "end_char": 1284, "text_sha256": "9da4317752d37da62129139affd33016e879d367c4cf58cfefb9200c663fe4ed"}
- experimental_model
- Human and rat transporter cDNA transfection into HEK293 cells with rat tissue distribution
- exposure
- Metformin uptake across five renal organic ion transporters and tissue accumulation in male rats
- limitations
- Relative capacities are transfection-dependent; the study itself notes that plasmid amount changes the apparent kinetics.
- nutrient_topic
- Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. · Metformin
- organism
- Human and rat transporters; rat in vivo
- plain_language
- The kidney transporter moves far more of the drug than the liver one does.
- primary_references
- [metformin-p16272756] Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1. (2005). https://pubmed.ncbi.nlm.nih.gov/16272756/ DOI: 10.2133/dmpk.20.379
- tissue_or_cell_type
- Kidney and liver
- transport_effect
- raises A transfected-cell capacity comparison, measured as metformin carried into the cell.
- transport_pool
- the expressing cell A transfected-cell capacity comparison, measured as metformin carried into the cell.
Metformin: transport, molecular targets, gut mechanisms and nutrient interactions (2026-09-19) · lines 177–188
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human and rat transporter cDNA transfection into HEK293 cells with rat tissue distribution · source_derived_draft · unverified_draft
### metformin-oct2-capacity Human and rat OCT2 had roughly 10-fold and 100-fold greater capacity to transport metformin than OCT1 in the transfected-cell comparison. Condition category: normal nutrient_topic: Metformin research collection; topical membership is not evidence of a direct clinical effect, and pharmacological exposure is not dietary intake. plain_language: The kidney transporter moves far more of the drug than the liver one does. organism: Human and rat transporters; rat in vivo tissue_or_cell_type: Kidney and liver experimental_model: Human and rat transporter cDNA transfection into HEK293 cells with rat tissue distribution limitations: Relative capacities are transfection-dependent; the study itself notes that plasmid amount changes the apparent kinetics. exposure: Metformin uptake across five renal organic ion transporters and tissue accumulation in male rats evidence_span: {"source_cache": "artifacts/metformin-research/16272756.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "9da4317752d37da62129139affd33016e879d367c4cf58cfefb9200c663fe4ed", "start_char": 0, "end_char": 1284, "text_sha256": "9da4317752d37da62129139affd33016e879d367c4cf58cfefb9200c663fe4ed"} [metformin-p16272756] Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1. (2005). https://pubmed.ncbi.nlm.nih.gov/16272756/ DOI: 10.2133/dmpk.20.379
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.